Petros Pharmaceuticals, Inc.

Q2 2024 13F Holders

Symbol
PTPI
CUSIP
71678J209
Type
Equity
Class
COM NEW
Num filings
14
Total reported value, excl. options
$94.9 k
Manager Report Date Value ($000) Shares Option Type